AMI TIRZ

Price range: R320,00 through R1 190,00

Choose Tirzepatide in 15mg, 30mg or 60mg, with vial, pen and cartridge options. Compare the listed amount and format before ordering.

Out of stock

  • Pens and cartridges are made on order.
  • Peptides are received, stored and shipped cold.
Pay byDirect bank transfer

For laboratory research use only. This product is not a medicine and is not for human or veterinary use. It is not intended to diagnose, treat, cure or prevent any disease.

SKU: ARP-tirzepatide Categories: ,

Tirzepatide has three listed strengths: 15mg, 30mg and 60mg. Each is offered as a vial, pen or cartridge, so you can keep the compound the same while comparing the catalogue options.
The discovery study describes tirzepatide, then called LY3298176, as a dual GIP and GLP-1 receptor agonist. This is research context, not a claim that Aminos stock is equivalent to a finished medicine or to material used in the study.
Compare the separate Semaglutide and Retatrutide listings if your specification calls for a different compound. Matching strength labels do not make them interchangeable.

Tirzepatide is a single modified peptide that activates GIP and GLP-1 receptors. Dual receptor activity does not mean it is a blend of two compounds.

Identity and context

The discovery designation is LY3298176. The original investigators describe a fatty-acid-modified peptide and assess both incretin receptors. Tirzepatide is a distinct chemical identity from semaglutide and from the triple-receptor agonist retatrutide; these names are not interchangeable.

Reference classification

Modified peptide. The linked catalogue product is Tirzepatide. This reference does not independently authenticate the material supplied.